IMS Consulting Group
IMS Consulting Group is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at IMS Consulting Group.
IMS Consulting Group is a company.
Key people at IMS Consulting Group.
Key people at IMS Consulting Group.
IMS Consulting Group is the world's leading specialized management consultancy focused on critical business issues in the life sciences sector, serving as the consulting arm of IMS Health (now part of IQVIA).[1][5][7] It provides end-to-end services including business unit strategy, therapy area and brand strategy, portfolio strategy, launch strategy, pricing & market access studies, and commercial model design and optimization for healthcare and pharmaceutical clients across 100+ countries.[1][3] Originally consolidated under IMS Health in 2011, it now operates within IQVIA, a global leader with 74,000+ employees headquartered in Durham, NC, generating significant revenue through healthcare data, analytics, and consulting.[3]
Note that multiple entities share similar names, such as an IT solutions firm specializing in Archibus, ServiceNow, and Esri for facility management,[2][4] a legal strategies consultancy,[6] and a hospitality management group in Indonesia.[8] This analysis centers on the prominent life sciences consultancy due to its scale, historical significance, and frequent mentions in professional databases.[1][3][5][7]
IMS traces its roots to 1954 when Bill Frohlich and David Dubow founded IMS as a market research company to enable strategic marketplace decisions in pharmaceuticals, quickly becoming the gold standard in Europe and Asia.[3] The firm expanded rapidly: entering Latin America in 1970, acquiring companies between 1973-1979 to broaden competencies, and launching the groundbreaking Multinational Integrated Data Analysis (MIDAS) system in 1979.[3] In 1988, Dun & Bradstreet acquired IMS for $1.7 billion; by 1998, it spun off as an independent NYSE-listed public company.[3]
IMS Consulting Group formalized in 2011 to consolidate IMS Health's consulting services under one roof, focusing on life sciences strategy.[3][1] In 2017, IMS Health merged with Quintiles to form IQVIA, integrating consulting into a broader healthcare intelligence powerhouse led by CEO Ari Bousbib.[3] This evolution shifted from pure data provision to comprehensive advisory, with operations now run by Managing Partner Ari Bousbib from Durham, NC.[3]
IMS Consulting Group rides the convergence of healthcare data analytics and AI-driven life sciences innovation, capitalizing on exploding demand for real-world evidence in drug development, pricing, and market access amid rising global healthcare costs.[1][3] Timing is ideal post-2017 IQVIA merger, aligning with trends like personalized medicine, regulatory pressures (e.g., value-based pricing), and digital health tools—market forces amplified by post-pandemic data needs and biotech funding surges.[3]
It influences the ecosystem by empowering pharma giants and biotechs with actionable insights, bridging data silos to accelerate launches and optimize commercial models; as part of IQVIA, it shapes industry standards in 100+ countries, fostering a data-centric shift that smaller players emulate.[1][3][7]
IMS Consulting Group, embedded in IQVIA, is poised for expansion in AI-augmented healthcare analytics and precision medicine, with trends like real-world data regulations and gene therapy booms driving demand for its specialized strategy services. Expect deeper integrations with emerging tech like predictive modeling for launches and market access, potentially growing its influence as biopharma invests billions in data platforms. Its evolution from niche research to global powerhouse positions it to lead the next wave of life sciences transformation, delivering outsized impact where data meets strategy.
